Cargando…
Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience
Anti-phospholipid syndrome is an autoimmune disorder characterized by episodes of arterial and/or venous thrombosis and/or pregnancy morbidity in the presence of anti-phospholipid antibodies. Catastrophic anti-phospholipid syndrome is an accelerated form of the disease with rapid involvement of mult...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928371/ https://www.ncbi.nlm.nih.gov/pubmed/35308057 http://dx.doi.org/10.1177/2050313X221085099 |
_version_ | 1784670627462905856 |
---|---|
author | Hegde, Arun Dorji, Thinley Asturkar, Vikram Yangzom, Sonam Bhanu, Kovilapu Uday |
author_facet | Hegde, Arun Dorji, Thinley Asturkar, Vikram Yangzom, Sonam Bhanu, Kovilapu Uday |
author_sort | Hegde, Arun |
collection | PubMed |
description | Anti-phospholipid syndrome is an autoimmune disorder characterized by episodes of arterial and/or venous thrombosis and/or pregnancy morbidity in the presence of anti-phospholipid antibodies. Catastrophic anti-phospholipid syndrome is an accelerated form of the disease with rapid involvement of multiple organ systems often posing a diagnostic challenge. There is a paucity of literature on the myriad presentations of catastrophic anti-phospholipid syndrome owing to the orphan nature of the disease. We present three cases of catastrophic anti-phospholipid syndrome in patients with systemic lupus erythematosus that presented with episodes of thrombosis involving both arterial and venous systems and multisystem organ failure. Timely diagnoses were made based on a high index of suspicion and were managed with a combination of systemic glucocorticoids, cyclophosphamide, plasmapheresis, intravenous immunoglobulin and other supportive measures. However, despite providing the standard of care, we encountered a poor outcome in two of these patients, highlighting the high mortality associated with catastrophic anti-phospholipid syndrome. |
format | Online Article Text |
id | pubmed-8928371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-89283712022-03-18 Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience Hegde, Arun Dorji, Thinley Asturkar, Vikram Yangzom, Sonam Bhanu, Kovilapu Uday SAGE Open Med Case Rep Case Report Anti-phospholipid syndrome is an autoimmune disorder characterized by episodes of arterial and/or venous thrombosis and/or pregnancy morbidity in the presence of anti-phospholipid antibodies. Catastrophic anti-phospholipid syndrome is an accelerated form of the disease with rapid involvement of multiple organ systems often posing a diagnostic challenge. There is a paucity of literature on the myriad presentations of catastrophic anti-phospholipid syndrome owing to the orphan nature of the disease. We present three cases of catastrophic anti-phospholipid syndrome in patients with systemic lupus erythematosus that presented with episodes of thrombosis involving both arterial and venous systems and multisystem organ failure. Timely diagnoses were made based on a high index of suspicion and were managed with a combination of systemic glucocorticoids, cyclophosphamide, plasmapheresis, intravenous immunoglobulin and other supportive measures. However, despite providing the standard of care, we encountered a poor outcome in two of these patients, highlighting the high mortality associated with catastrophic anti-phospholipid syndrome. SAGE Publications 2022-03-15 /pmc/articles/PMC8928371/ /pubmed/35308057 http://dx.doi.org/10.1177/2050313X221085099 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Hegde, Arun Dorji, Thinley Asturkar, Vikram Yangzom, Sonam Bhanu, Kovilapu Uday Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience |
title | Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience |
title_full | Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience |
title_fullStr | Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience |
title_full_unstemmed | Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience |
title_short | Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience |
title_sort | cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: an experience |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928371/ https://www.ncbi.nlm.nih.gov/pubmed/35308057 http://dx.doi.org/10.1177/2050313X221085099 |
work_keys_str_mv | AT hegdearun casesofcatastrophicantiphospholipidsyndromeinsystemiclupuserythematosusanexperience AT dorjithinley casesofcatastrophicantiphospholipidsyndromeinsystemiclupuserythematosusanexperience AT asturkarvikram casesofcatastrophicantiphospholipidsyndromeinsystemiclupuserythematosusanexperience AT yangzomsonam casesofcatastrophicantiphospholipidsyndromeinsystemiclupuserythematosusanexperience AT bhanukovilapuuday casesofcatastrophicantiphospholipidsyndromeinsystemiclupuserythematosusanexperience |